Description
HGH-FRAG 176–191 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | HGH-FRAG 176–191 |
| Also listed as | hGH (176–191); somatotropin fragment 176–191 |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| Sequence (commonly cited) | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| CAS (commonly cited) | 66004-57-7 |
| Approx. mass | ~1815 Da |
| Class | Synthetic C-terminal GH fragment |
| Intended use | Laboratory / in-vitro research only |
Not intact hGH / somatropin. Not IGF-1. Confirm whether the lot is unmodified 176–191 or AOD-9604 (Tyr-modified 177–191) on the COA.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
hGH (176–191) is a C-terminal fragment of somatotropin used in biochemical papers on GH-domain structure. A related, modified analogue (AOD-9604) appears in metabolic-assay literature associated with Australian GH-fragment programmes.
Those papers are experimental. They are not fat-loss claims for this vial. Fragment lots and AOD-9604 lots are not interchangeable without the COA.
Intact GH and GH fragments appear in WADA discussions. Licensed somatropin products are separate medicines. There is no UK marketing authorisation for this fragment vial.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.